Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial

医学 内科学 胃肠病学 不利影响 炎症性肠病 疾病 外科
作者
Timo Räth,Raja Atreya,Julia Bodenschatz,Wolfgang Uter,Carol Geppert,Francesco Vitali,Sarah Fischer,Maximilian J. Waldner,Jean‐Frédéric Colombel,Arndt Hartmann,Markus F. Neurath
出处
期刊:Gastroenterology [Elsevier BV]
卷期号:164 (2): 241-255 被引量:69
标识
DOI:10.1053/j.gastro.2022.10.014
摘要

Endoscopic and histologic remission have emerged as key therapeutic goals in the management of inflammatory bowel diseases (IBD) that are associated with favorable long-term disease outcomes. Here, we prospectively compared the predictive value of barrier healing with endoscopic and histologic remission for predicting long-term disease behavior in a large cohort of patients with IBD in clinical remission.At baseline, patients with IBD in clinical remission underwent ileocolonoscopy with assessment of intestinal barrier function by confocal endomicroscopy. Endoscopic and histologic disease activity, as well as barrier healing, was prospectively assessed along established scores. During subsequent follow-up, patients were closely monitored for clinical disease activity and the occurrence of major adverse outcomes (MAOs): disease flares, IBD-related hospitalization or surgery, and initiation or dose escalation of systemic steroids, immunosuppressants, small molecules, or biological therapy.The final analysis included 181 patients, 100 with Crohn's disease [CD] and 81 with ulcerative colitis (UC). During a mean follow-up of 35 (CD) and 25 (UC) months, 73% of patients with CD and 69% of patients with UC experienced at least 1 MAO. The probability of MAO-free survival was significantly higher in patients with IBD with endoscopic remission compared with endoscopically active disease. In addition, histologic remission predicted MAO-free survival in patients with UC but not CD. Barrier healing on endomicroscopy was superior to endoscopic and histologic remission for predicting MAO-free survival in both UC and CD.Barrier healing is associated with decreased risk of disease progression in patients with clinically remittent IBD, with superior predictive performance compared with endoscopic and histologic remission. Analysis of barrier function might be considered as a future treatment target in clinical trials.gov number, NCT05157750.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雪花发布了新的文献求助10
2秒前
秀丽笑容完成签到 ,获得积分10
6秒前
江湖应助聪慧芷巧采纳,获得10
7秒前
量子星尘发布了新的文献求助10
8秒前
Rjy完成签到 ,获得积分10
14秒前
性感母蟑螂完成签到 ,获得积分10
20秒前
ruochenzu完成签到,获得积分10
22秒前
陈尹蓝完成签到 ,获得积分10
23秒前
天道酬勤完成签到,获得积分10
25秒前
27秒前
仁爱的谷南完成签到,获得积分10
27秒前
雯雯完成签到 ,获得积分10
29秒前
一路有你完成签到 ,获得积分10
29秒前
30秒前
ruochenzu发布了新的文献求助10
30秒前
32秒前
wanghao完成签到 ,获得积分10
33秒前
图图发布了新的文献求助10
33秒前
十三完成签到 ,获得积分10
33秒前
聪慧芷巧完成签到,获得积分10
34秒前
米博士完成签到,获得积分10
35秒前
研友_VZGVzn完成签到,获得积分10
36秒前
Cheung2121发布了新的文献求助30
37秒前
黄芩完成签到 ,获得积分10
38秒前
55秒前
秋半梦完成签到,获得积分10
57秒前
李爱国应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
搜集达人应助科研通管家采纳,获得10
1分钟前
打地鼠工人完成签到,获得积分10
1分钟前
彩色半烟完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
Ning完成签到,获得积分10
1分钟前
图图完成签到,获得积分10
1分钟前
勤奋的灯完成签到 ,获得积分10
1分钟前
ludong_0完成签到,获得积分10
1分钟前
Asumita完成签到,获得积分10
1分钟前
双青豆完成签到 ,获得积分10
1分钟前
1分钟前
fxy完成签到 ,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022